Wyskiel Christina W 4
4 · CARDIOVASCULAR SYSTEMS INC · Filed Feb 27, 2009
Insider Transaction Report
Form 4
Wyskiel Christina W
Director
Transactions
- Disposition from Tender
Stock Options
2009-02-25−23,319→ 0 totalExercise: $7.36From: 2007-11-13Exp: 2017-11-12→ Common Stock (23,319 underlying) - Disposition from Tender
Stock Options
2009-02-25−6,681→ 0 totalExercise: $5.11From: 2007-10-09Exp: 2017-10-08→ Common Stock (6,681 underlying) - Disposition from Tender
Stock Options
2009-02-25−40,000→ 0 totalExercise: $5.71Exp: 2011-08-14→ Common Stock (40,000 underlying)
Footnotes (5)
- [F1]These Stock Options are held by Christina Wyskiel for the benefit of Maverick Fund, L.D.C., Maverick Fund USA, Ltd., and Maverick Fund II, Ltd. Ms. Wyskiel is an employee of an affiliate of Maverick Capital Ltd.
- [F2]These Stock Options are exercisable in three equal annual installments. The first installment became exercisable on August 15, 2007, the second installment became exercisable on August 15, 2008, and the third installment will become exercisable on August 15, 2009.
- [F3]Pursuant to the merger agreement between Replidyne, Inc., Responder Merger Sub, Inc. and the issuer, dated November 3, 2008, (the "Merger Agreement"), these Stock Options were assumed on 02/25/2009 by Replidyne, Inc. and replaced with options to purchase 15,087 shares of Replidyne, Inc. common stock at an exercise price of $11.38 and otherwise having the same terms and conditions as the assumed Stock Options.
- [F4]Pursuant to the Merger Agreement, these Stock Options were assumed on 02/25/2009 by Replidyne, Inc. and replaced with a stock option to purchase 4,322 shares of Replidyne, Inc. common stock at an exercise price of $7.90 and otherwise having the same terms and conditions as the assumed Stock Options.
- [F5]Pursuant to the Merger Agreement, these Stock Options were assumed on 02/25/2009 by Replidyne, Inc. and replaced with a stock option to purchase 25,880 shares of Replidyne, Inc. common stock at an exercise price of $8.83 and otherwise having the same terms and conditions as the assumed Stock Options.